Zobrazeno 1 - 10
of 404
pro vyhledávání: '"Sonali M, Smith"'
Autor:
Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng Bi, the North American Mantle Cell Lymphoma Consortium
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background Patients with mantle cell lymphoma (MCL) exhibit a wide variation in clinical presentation and outcome. However, the commonly used prognostic models are outdated and inadequate to address the needs of the current multidisciplinary
Externí odkaz:
https://doaj.org/article/38f17dfbe7af46e394e36a8885eeec63
Autor:
Sonali M. Smith
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/9a92c394b9be43a981853ad366a90fbe
Autor:
Yuanyuan Zha, Xiufen Chen, James Godfrey, Girish Venkataraman, Justin P Kline, Aleksander Bagaev, Jovian Yu, Nicole Sunseri, Alan Cooper, Arina Varlamova, Dmitry Zarubin, Yuriy Popov, Connor Jacobson, Ekaterina Postovalova, Zhongmin Xiang, Krystle Nomie, Sravya Tumuluru, Sonali M Smith
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background PD-1 checkpoint blockade therapy (CBT) has greatly benefited patients with select solid tumors and lymphomas but has limited efficacy against diffuse large B-cell lymphoma (DLBCL). Because numerous inhibitory checkpoint receptors have been
Externí odkaz:
https://doaj.org/article/4f9de0e70e7e43809db62f8d3b1fab29
Autor:
Alexandra E. Rojek, Sonali M. Smith
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 2, Pp 1-8 (2022)
Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL), with limited-stage DLBCL defined as stage I or II disease. Risk stratification, initial treatment options, and relapse patterns are distinct from advanced-s
Externí odkaz:
https://doaj.org/article/42fb09e08d8f4adbb58ba42b62600396
Autor:
Brian C.-H. Chiu, Chang Chen, Qiancheng You, Rudyard Chiu, Girish Venkataraman, Chang Zeng, Zhou Zhang, Xiaolong Cui, Sonali M. Smith, Chuan He, Wei Zhang
Publikováno v:
npj Genomic Medicine, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract The 5-methylcytosines (5mC) have been implicated in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). However, the role of 5-hydroxymethylcytosines (5hmC) that are generated from 5mC through active demet
Externí odkaz:
https://doaj.org/article/c07415f9cf8248ff98fd82fcb6e0f829
Autor:
Deborah M. Stephens, Hongli Li, Louis S. Constine, Thomas J. Fitzgerald, John P. Leonard, Brad S. Kahl, Joo Y. Song, Michael L. LeBlanc, Sonali M. Smith, Daniel O. Persky, Jonathan W. Friedberg
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/5fdfadeacffd43749e9f9f34bd7dde3a
Autor:
Sonali M. Smith, Gilles Salles
Publikováno v:
Haematologica, Vol 107, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/59529a0ed6944f7fa8802cab08193236
Autor:
Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3132-3135 (2019)
Externí odkaz:
https://doaj.org/article/f4c13fc2d47a4df6a096154453dcd84a
Autor:
Brian C.-H. Chiu, Zhou Zhang, Qiancheng You, Chang Zeng, Elizabeth Stepniak, Paige M. Bracci, Kangkang Yu, Girish Venkataraman, Sonali M. Smith, Chuan He, Wei Zhang
Publikováno v:
Blood Advances, Vol 3, Iss 19, Pp 2790-2799 (2019)
Abstract: An elevated level of circulating cell-free DNA (cfDNA) has been associated with tumor bulk and poor prognosis in diffuse large B-cell lymphoma (DLBCL), but the tumor-specific molecular alterations in cfDNA with prognostic significance remai
Externí odkaz:
https://doaj.org/article/da1932801e0f40428d500e1bd791b7d5
Autor:
Ajay Major, Justin Kline, Theodore G. Karrison, Paul A. S. Fishkin, Amy S. Kimball, Adam M. Petrich, Sreenivasa Nattam, Krishna Rao, Bethany G. Sleckman, Kenneth Cohen, Koen van Besien, Aaron P. Rapoport, Sonali M. Smith
Publikováno v:
Haematologica, Vol 107, Iss 7 (2021)
The PI3K/Akt/mTOR (PAM) axis is constitutively activated in multiple lymphoma subtypes and is a promising therapeutic target. The mTOR inhibitor temsirolimus (TEM) and the immunomodulatory agent lenalidomide (LEN) have overlapping effects within the
Externí odkaz:
https://doaj.org/article/da69c238a67c488eac97c5b0995a9e46